Actively Recruiting
CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer
Led by Tel-Aviv Sourasky Medical Center · Updated on 2024-10-24
2000
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
T
Tel-Aviv Sourasky Medical Center
Lead Sponsor
T
Tel Aviv Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the researchers is to test whether the CancerenD24 index, an algorithm based on the quantitative value of CD24, CD11b, clinical and laboratory characteristics, developed in the laboratory can help in the early detection of a malignant disease in a population of healthy subjects.
CONDITIONS
Official Title
CancerenD24 Screening as an Aid to the Clinician for the Diagnosis of Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Completion of all medical exams and questionnaires including cancer diagnoses, demographic data and other epidemiologic information
- Willing and able to sign an informed consent
- Age 60 years
You will not qualify if you...
- Age < 40 years
- Pregnancy or breastfeeding
- Any type of fever
- Any cancer active at study entry or up to 5 years prior to study entry
- Polyposis syndromes
- Inflammatory bowel disease
- Unwilling or unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Integrated Cancer Prevention Center at the Tel Aviv Sourasky Medical Center Ichilov
Tel Aviv, Israel, 64239
Actively Recruiting
Research Team
N
Nadir Arber, Professor
CONTACT
S
Shiran Shapira, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here